Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Common Stock | 47.8K | $93.6K | $1.96 | Oct 3, 2024 | Direct |
Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Restricted Stock Unit | 16.7K | $45.2K | $2.71 | Jan 15, 2024 | Direct |
Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Restricted Stock Unit | 0 | $0 | $1.96 | Oct 1, 2024 | Direct |
Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Stock Option (Right to Buy) | 75K | Jan 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRSN | Mersana Therapeutics, Inc. | Oct 1, 2024 | 4 | -$16.3K | 4 | Oct 7, 2024 | VP, Chief Accounting Officer |
MRSN | Mersana Therapeutics, Inc. | Jan 13, 2024 | 0 | $0 | 4/A | Feb 16, 2024 | VP, Chief Accounting Officer |
MRSN | Mersana Therapeutics, Inc. | Jan 13, 2024 | 11 | -$13.6K | 4 | Jan 17, 2024 | VP, Chief Accounting Officer |
MRSN | Mersana Therapeutics, Inc. | Sep 5, 2023 | 1 | $0 | 4 | Sep 7, 2023 | VP, Chief Accounting Officer |
MRSN | Mersana Therapeutics, Inc. | Jan 13, 2023 | 9 | -$20.5K | 4 | Jan 18, 2023 | VP, Controller |
MRSN | Mersana Therapeutics, Inc. | Jan 14, 2022 | 6 | -$11.7K | 4 | Jan 19, 2022 | VP, Controller |
MRSN | Mersana Therapeutics, Inc. | Jul 1, 2021 | 1 | -$12.8K | 4 | Jul 2, 2021 | VP, Controller |